Achieve Life Sciences Inc (ACHV): Next-Year EPS Estimate 35.48%
As of 2026-06-04, Achieve Life Sciences Inc (ACHV) has a next-year EPS growth estimate of 35.48%.
On 2026-05-21, analyst consensus for ACHV's next-year EPS growth shifted from 35.46% to 35.48% — a positive change of 0.02 percentage points. The revised estimate has been sustained across 11 subsequent trading sessions. Current-year growth is projected at 42.82%.
Current Snapshot
- Sector
- Healthcare
- Industry
- Biotechnology
- EPS growth next year
- 35.48%
- EPS growth this year
- 42.82%
- EPS next quarter (est)
- -$0.16
- Last price
- $5.29
EPS Revision History
| Date | EPS Next Y | EPS This Y | Next Q (est) | Price |
|---|---|---|---|---|
| 2026-06-04 | 35.48% | 42.82% | -$0.16 | $5.29 |
| 2026-06-03 | 35.48% | 42.82% | -$0.16 | $4.92 |
| 2026-06-02 | 35.48% | 42.82% | -$0.16 | $5.03 |
| 2026-06-01 | 35.48% | 42.82% | -$0.16 | $5.30 |
| 2026-05-31 | 35.48% | 42.82% | -$0.16 | $5.24 |
| 2026-05-28 | 35.48% | 42.82% | -$0.16 | $5.30 |
| 2026-05-27 | 35.48% | 42.82% | -$0.16 | $4.78 |
| 2026-05-26 | 35.48% | 42.82% | -$0.16 | $4.56 |
| 2026-05-25 | 35.48% | 42.82% | -$0.16 | $4.69 |
| 2026-05-24 | 35.48% | 42.82% | -$0.16 | $4.69 |
| 2026-05-21 | 35.48% | 42.82% | -$0.16 | $4.60 |
| 2026-05-20 | 35.46% | 42.84% | -$0.16 | $4.57 |
| 2026-05-19 | 35.46% | 42.84% | -$0.16 | $4.45 |
| 2026-05-18 | 35.46% | 42.84% | -$0.16 | $4.77 |
| 2026-05-17 | 37.73% | 40.90% | -$0.16 | $5.29 |
| 2026-05-14 | 37.73% | 40.90% | -$0.16 | $5.79 |
| 2026-05-13 | 33.83% | 38.86% | -$0.16 | $6.03 |
| 2026-05-12 | 33.03% | 16.97% | -$0.22 | $5.99 |
| 2026-04-20 | 25.78% | -5.94% | -$0.30 | $4.25 |
| 2026-04-19 | 25.78% | -5.94% | -$0.30 | $5.10 |
| 2026-04-16 | 25.78% | -5.94% | -$0.30 | $4.81 |
| 2026-04-15 | 25.78% | -5.94% | -$0.30 | $3.55 |
| 2026-04-14 | 25.78% | -5.94% | -$0.30 | $3.61 |
| 2026-04-13 | 25.78% | -5.94% | -$0.30 | $3.58 |
| 2026-04-12 | 25.78% | -5.94% | -$0.30 | $3.49 |
| 2026-04-10 | 25.78% | -5.94% | -$0.30 | $3.39 |
| 2026-04-09 | 25.78% | -5.94% | -$0.30 | $3.32 |
| 2026-04-08 | 25.78% | N/A | -$0.30 | $3.26 |
| 2026-04-07 | 25.78% | N/A | -$0.30 | $3.20 |
| 2026-04-06 | 25.78% | N/A | -$0.30 | $3.20 |
Recent News
- Achieve Life Sciences Inc (ACHV) Q1 2026 Earnings Call Highlights: Strategic Financing and ...GuruFocus.com
- Achieve Life Sciences Strengthens Board and Commercial Leadership with Three Senior Appointments from Team Previously at Verona PharmaGlobeNewswire
- Achieve Life Sciences Reports First Quarter 2026 Financial Results and Provides Business UpdatesGlobeNewswire
- Achieve Life Sciences Inc (ACHV) Q4 2025 Earnings Call Highlights: Strategic Advances and ...GuruFocus.com
- Achieve Life Sciences Shareholders Are Encouraged to Reach Out to Johnson Fistel for More Information About Potentially Recovering Their LossesNewsfile
- Achieve Life Sciences Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business UpdatesGlobeNewswire
Screen Performance
Aggregate stats across all 1761 tickers our top-EPS-revision screen has flagged over the past 64 days.
- Median return since detection
- +5.1%
- % of tickers in the green
- 62%
- Median return on winners
- +17.5%
- Large revisions captured
- 746
Past detection performance reflects the price change between when a ticker first entered our screen and the most recent observation. Not a forward-looking forecast.
Frequently Asked Questions
What is Achieve Life Sciences Inc's next-year EPS growth estimate?▾
As of 2026-06-04, Achieve Life Sciences Inc (ACHV) has a next-year EPS growth estimate of 35.48%, based on analyst consensus.
When was the latest EPS estimate revision for ACHV?▾
The most recent revision occurred on 2026-05-21, when analysts adjusted the next-year EPS growth estimate from 35.46% to 35.48%.
What sector and industry does Achieve Life Sciences Inc belong to?▾
Achieve Life Sciences Inc operates in the Healthcare sector, specifically the Biotechnology industry.
How often is this EPS estimate data updated?▾
EPS revision data is refreshed daily from analyst consensus estimates. ACHV appears on this page because it was flagged by our daily top-EPS-revision-performer screen.
EPS revision data sourced from analyst consensus estimates, refreshed daily. Achieve Life Sciences Inc (ACHV) appears here because it was detected by our daily top-EPS-revision-performer screen.
← All reports